130 related articles for article (PubMed ID: 31083605)
1. Combinatorial Use of Chitosan Nanoparticles, Reversine, and Ionising Radiation on Breast Cancer Cells Associated with Mitosis Deregulation.
Piña Olmos S; Díaz Torres R; Elbakrawy E; Hughes L; Mckenna J; Hill MA; Kadhim M; Ramírez Noguera P; Bolanos-Garcia VM
Biomolecules; 2019 May; 9(5):. PubMed ID: 31083605
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of reversine selectivity in inhibiting Mps1 more potently than aurora B kinase.
Hiruma Y; Koch A; Dharadhar S; Joosten RP; Perrakis A
Proteins; 2016 Dec; 84(12):1761-1766. PubMed ID: 27699881
[TBL] [Abstract][Full Text] [Related]
3. Preferential killing of p53-deficient cancer cells by reversine.
Jemaà M; Galluzzi L; Kepp O; Boilève A; Lissa D; Senovilla L; Harper F; Pierron G; Berardinelli F; Antoccia A; Castedo M; Vitale I; Kroemer G
Cell Cycle; 2012 Jun; 11(11):2149-58. PubMed ID: 22592527
[TBL] [Abstract][Full Text] [Related]
4. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells.
D'Alise AM; Amabile G; Iovino M; Di Giorgio FP; Bartiromo M; Sessa F; Villa F; Musacchio A; Cortese R
Mol Cancer Ther; 2008 May; 7(5):1140-9. PubMed ID: 18483302
[TBL] [Abstract][Full Text] [Related]
5. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition.
Jemaà M; Manic G; Lledo G; Lissa D; Reynes C; Morin N; Chibon F; Sistigu A; Castedo M; Vitale I; Kroemer G; Abrieu A
Oncotarget; 2016 Jan; 7(1):885-901. PubMed ID: 26637805
[TBL] [Abstract][Full Text] [Related]
6. Reversine triggers mitotic catastrophe and apoptosis in K562 cells.
Rodrigues Alves AP; Machado-Neto JA; Scheucher PS; Paiva HH; Simões BP; Rego EM; Traina F
Leuk Res; 2016 Sep; 48():26-31. PubMed ID: 27447890
[TBL] [Abstract][Full Text] [Related]
7. Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures.
Hiruma Y; Koch A; Hazraty N; Tsakou F; Medema RH; Joosten RP; Perrakis A
J Biol Chem; 2017 Sep; 292(35):14496-14504. PubMed ID: 28726638
[TBL] [Abstract][Full Text] [Related]
8. Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity.
Wengner AM; Siemeister G; Koppitz M; Schulze V; Kosemund D; Klar U; Stoeckigt D; Neuhaus R; Lienau P; Bader B; Prechtl S; Raschke M; Frisk AL; von Ahsen O; Michels M; Kreft B; von Nussbaum F; Brands M; Mumberg D; Ziegelbauer K
Mol Cancer Ther; 2016 Apr; 15(4):583-92. PubMed ID: 26832791
[TBL] [Abstract][Full Text] [Related]
9. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
[TBL] [Abstract][Full Text] [Related]
10. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia.
Carlos JAEG; Lima K; Coelho-Silva JL; de Melo Alves-Paiva R; Moreno NC; Vicari HP; de Souza Santos FP; Hamerschlak N; Costa-Lotufo LV; Traina F; Machado-Neto JA
Cell Oncol (Dordr); 2020 Dec; 43(6):1191-1201. PubMed ID: 32857324
[TBL] [Abstract][Full Text] [Related]
11. Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility.
Martinez R; Blasina A; Hallin JF; Hu W; Rymer I; Fan J; Hoffman RL; Murphy S; Marx M; Yanochko G; Trajkovic D; Dinh D; Timofeevski S; Zhu Z; Sun P; Lappin PB; Murray BW
PLoS One; 2015; 10(9):e0138616. PubMed ID: 26398286
[TBL] [Abstract][Full Text] [Related]
12. Insights into Resistance Mechanisms of Inhibitors to Mps1 C604Y Mutation via a Comprehensive Molecular Modeling Study.
Chen Y; Yu W; Jiang CC; Zheng JG
Molecules; 2018 Jun; 23(6):. PubMed ID: 29925769
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1.
Tardif KD; Rogers A; Cassiano J; Roth BL; Cimbora DM; McKinnon R; Peterson A; Douce TB; Robinson R; Dorweiler I; Davis T; Hess MA; Ostanin K; Papac DI; Baichwal V; McAlexander I; Willardsen JA; Saunders M; Christophe H; Kumar DV; Wettstein DA; Carlson RO; Williams BL
Mol Cancer Ther; 2011 Dec; 10(12):2267-75. PubMed ID: 21980130
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.
Thu KL; Silvester J; Elliott MJ; Ba-Alawi W; Duncan MH; Elia AC; Mer AS; Smirnov P; Safikhani Z; Haibe-Kains B; Mak TW; Cescon DW
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1570-E1577. PubMed ID: 29378962
[TBL] [Abstract][Full Text] [Related]
15. Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells.
Kuo CH; Lu YC; Tseng YS; Shi CS; Chen SH; Chen PT; Wu FL; Chang YP; Lee YR
Breast Cancer; 2014 May; 21(3):358-69. PubMed ID: 22926505
[TBL] [Abstract][Full Text] [Related]
16. Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase.
Colombo R; Caldarelli M; Mennecozzi M; Giorgini ML; Sola F; Cappella P; Perrera C; Depaolini SR; Rusconi L; Cucchi U; Avanzi N; Bertrand JA; Bossi RT; Pesenti E; Galvani A; Isacchi A; Colotta F; Donati D; Moll J
Cancer Res; 2010 Dec; 70(24):10255-64. PubMed ID: 21159646
[TBL] [Abstract][Full Text] [Related]
17. Imbalance of the spindle-assembly checkpoint promotes spindle poison-mediated cytotoxicity with distinct kinetics.
Zeng X; Xu WK; Lok TM; Ma HT; Poon RYC
Cell Death Dis; 2019 Apr; 10(4):314. PubMed ID: 30952840
[TBL] [Abstract][Full Text] [Related]
18. Targeting Mitosis in Cancer: Emerging Strategies.
Dominguez-Brauer C; Thu KL; Mason JM; Blaser H; Bray MR; Mak TW
Mol Cell; 2015 Nov; 60(4):524-36. PubMed ID: 26590712
[TBL] [Abstract][Full Text] [Related]
19. Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division.
Maia ARR; Linder S; Song JY; Vaarting C; Boon U; Pritchard CEJ; Velds A; Huijbers IJ; van Tellingen O; Jonkers J; Medema RH
Br J Cancer; 2018 Jun; 118(12):1586-1595. PubMed ID: 29736010
[TBL] [Abstract][Full Text] [Related]
20. TC Mps1 12, a novel Mps1 inhibitor, suppresses the growth of hepatocellular carcinoma cells via the accumulation of chromosomal instability.
Choi M; Min YH; Pyo J; Lee CW; Jang CY; Kim JE
Br J Pharmacol; 2017 Jun; 174(12):1810-1825. PubMed ID: 28299790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]